1. Home
  2. ADPT vs UNFI Comparison

ADPT vs UNFI Comparison

Compare ADPT & UNFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • UNFI
  • Stock Information
  • Founded
  • ADPT 2009
  • UNFI 1976
  • Country
  • ADPT United States
  • UNFI United States
  • Employees
  • ADPT N/A
  • UNFI N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • UNFI Food Distributors
  • Sector
  • ADPT Health Care
  • UNFI Consumer Discretionary
  • Exchange
  • ADPT Nasdaq
  • UNFI Nasdaq
  • Market Cap
  • ADPT 1.8B
  • UNFI 1.7B
  • IPO Year
  • ADPT 2019
  • UNFI 1996
  • Fundamental
  • Price
  • ADPT $12.85
  • UNFI $28.91
  • Analyst Decision
  • ADPT Strong Buy
  • UNFI Hold
  • Analyst Count
  • ADPT 8
  • UNFI 8
  • Target Price
  • ADPT $12.38
  • UNFI $27.00
  • AVG Volume (30 Days)
  • ADPT 1.8M
  • UNFI 752.0K
  • Earning Date
  • ADPT 08-05-2025
  • UNFI 09-30-2025
  • Dividend Yield
  • ADPT N/A
  • UNFI N/A
  • EPS Growth
  • ADPT N/A
  • UNFI N/A
  • EPS
  • ADPT N/A
  • UNFI N/A
  • Revenue
  • ADPT $205,216,000.00
  • UNFI $32,243,000,000.00
  • Revenue This Year
  • ADPT $32.76
  • UNFI $4.46
  • Revenue Next Year
  • ADPT $15.81
  • UNFI $1.25
  • P/E Ratio
  • ADPT N/A
  • UNFI N/A
  • Revenue Growth
  • ADPT 21.60
  • UNFI 6.62
  • 52 Week Low
  • ADPT $3.98
  • UNFI $13.84
  • 52 Week High
  • ADPT $13.52
  • UNFI $34.76
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 57.00
  • UNFI 63.77
  • Support Level
  • ADPT $12.62
  • UNFI $27.63
  • Resistance Level
  • ADPT $13.25
  • UNFI $28.12
  • Average True Range (ATR)
  • ADPT 0.55
  • UNFI 0.72
  • MACD
  • ADPT -0.05
  • UNFI 0.12
  • Stochastic Oscillator
  • ADPT 58.13
  • UNFI 88.82

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.

Share on Social Networks: